The Vanguard Group 13D and 13G filings for Utah Medical Products, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 6:02 pm Unchanged |
2024-09-30 | 13G | Utah Medical Products, Inc. UTMD |
The Vanguard Group | 181,169 5.210% |
0 (Unchanged) |
Filing |
| 2024-11-04 2:00 pm Purchase |
2024-09-30 | 13G | Utah Medical Products, Inc. UTMD |
The Vanguard Group | 181,169 5.210% |
13,479 (+8.04%) |
Filing |
| 2023-02-09 11:35 am Sale |
2022-12-30 | 13G | Utah Medical Products, Inc. UTMD |
The Vanguard Group | 167,690 4.620% |
-21,883 (-11.54%) |
Filing |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Utah Medical Products, Inc. UTMD |
The Vanguard Group | 189,573 5.190% |
636 (+0.34%) |
Filing |
| 2021-02-10 11:57 am Purchase |
2020-12-31 | 13G | Utah Medical Products, Inc. UTMD |
The Vanguard Group | 188,937 5.190% |
188,937 (New Position) |
Filing |